000 01398 a2200385 4500
005 20250513121328.0
264 0 _c19970804
008 199708s 0 0 eng d
022 _a0300-5127
024 7 _a10.1042/bst025201s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlexandroff, A B
245 0 0 _aIs the success of BCG tumour immunotherapy due to the induction of co-stimulatory molecules?
_h[electronic resource]
260 _bBiochemical Society transactions
_cMay 1997
300 _a201S p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Intravesical
650 0 4 _aAntigens, CD
_xbiosynthesis
650 0 4 _aB7-1 Antigen
_xbiosynthesis
650 0 4 _aBCG Vaccine
_xadministration & dosage
650 0 4 _aCD40 Antigens
_xbiosynthesis
650 0 4 _aCarcinoma, Transitional Cell
_ximmunology
650 0 4 _aCell Line
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aIntercellular Adhesion Molecule-1
_xbiosynthesis
650 0 4 _aSignal Transduction
650 0 4 _aTumor Cells, Cultured
650 0 4 _aUrinary Bladder Neoplasms
_ximmunology
700 1 _aMitchell, I
700 1 _aBlack, J
700 1 _aJames, K
773 0 _tBiochemical Society transactions
_gvol. 25
_gno. 2
_gp. 201S
856 4 0 _uhttps://doi.org/10.1042/bst025201s
_zAvailable from publisher's website
999 _c9171872
_d9171872